Table 3 Laboratory data and sustained virological response of studied groups

HCV RNA by PCR

(10⁶ u/l)

5.56 ± 0.24

4.3 ± 0.15

7.17 ± 0.32

0.741

0.116

ALT (u/l)

42.99 ± 20.74

41.64 ± 18.69

44.79 ± 23.20

0.98

0.235

AST (u/l)

40.85 ± 30.37

38.48 ± 32.98

44 ± 26.43

1.173

0.574

Bilirubin (mg/dl)

0.91 ± 0.29

0.89 ± 0.27

0.93 ± 0.34

0.668

0.118

Albumin (g/dl)

3.99 ± 0.44

3.97 ± 0.46

4 ± 0.44

0.483

0.239

Hemoglobin (mg/dl)

13.28 ± 1.39

13.35 ± 1.43

13.19 ± 1.34

0.724

0.272

Leucocytes (10³/ul)

6.39 ± 1.56

6.51 ± 1.62

6.21 ± 1.48

1.237

0.203

Platelets (10³/ul)

231.41 ± 52.40

229.98 ± 52.65

233.30 ± 52.37

0.408

0.854

Creatinine (mg/dl)

1.57 ± 7.36

2.01 ± 9.7

0.98 ± 0.19

0.903

0.107

INR

1.06 ± 0.109

1.06 ± 0.11

1.06 ± 0.104

0.393

0.964

After treatment (12 weeks)

 SVR

2.41

0.12

  Achieved

163 (95.9%)

95 (97.9%)

68 (93.2%)

  Not achieved

7 (4.1%)

2 (2.1%)

5 (6.8%)